跳至主要内容
临床试验/NCT03381911
NCT03381911已完成不适用

Embodied Conversational Agent as Consent Advocate Compared to E-Consent Administration

Boston Medical Center2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2018年1月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Knowledge of informed consent document

研究概览

简要总结

This study will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and understanding consent forms on their own as a supplement to the normal consent process done in research settings.

In a prior study, the investigators delivered a similar protocol, where subjects were first consented and then given a mock consent form (administered in 1 of 3 arms: RA, ECA, or ECA + RA). Subjects in this protocol struggled with the concept of a "mock" consent process, especially after they had just completed a consent process for the study itself. The current protocol, using deception research methods, aims to provide a more pure assessment of ECA consent vs the standard (here, E-consent) by waiving consent and delivering the sham consent as if it were reality. In the context of a protocol that employs deception methods, participants in the current study would be invited as healthy volunteers, and be randomized to 1 of 2 different consent processes to evaluate the relative benefits of different approaches for informed consent. After the knowledge tests have been completed, subjects will undergo a debriefing where they are made fully aware of the deception and its purpose. At that time, subjects will also be given the opportunity to "opt out" and not have their data included in the study results.

详细描述

Participants who call in response to the clinic flyers will first confirm eligibility criteria of age (≥21) and language (able to complete a study visit in English). Once eligibility is confirmed, participants will be scheduled to come to BMC for a single study visit that will take approximately 60-90 minutes. Randomization to one study arm or the other will occur when subject arrives for appointment.

The following activities will occur at a single study visit:

  1. administer sham consent (via e-consent or ECA per randomization result)

  2. knowledge test

  3. data collection

  4. socio-demographics

  5. health literacy assessment (REALM)

  6. ECA satisfaction (for ECA arm subjects only)

  7. Emotional connection (adapted PROMIS) (for ECA arm subjects only)

  8. Debriefing

  9. Describe true study aims

  10. Opt out option (subject can request that their data not be used)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English speaking
  • able to come in for a single study visit

排除标准

  • 未提供

研究组 & 干预措施

E-Consent

No Intervention

This arm is the standard of care, where the consent form is presented to the subject on a computer screen and he/she can scroll ahead and back as needed. There is also an option to have each screen read aloud.

ECA Consent

Experimental

In this arm an Embodied Conversational Agent (ECA) which is a computer generated character reads the consent form aloud to the subject, and also describes each section using a pre-loaded script. In addition, the character performs "teach-back", where she asks the subject a question about the section that was just described, and then repeats the section if the question is answered incorrectly.

干预措施: Embodied Conversational Agent (Other)

结局指标

主要结局

Knowledge of informed consent document

时间窗: immediately following the study interview

A knowledge test will be given to assess the subjects' level of comprehension of the informed consent form

次要结局

  • Survey of level of satisfaction with the ECA(immediately following the study interview)
  • Amount of time spent on consent process(immediately following the study interview)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Paasche-Orlow

Professor, Dept General Internal Medicine, BUSM

Boston Medical Center

研究点 (2)

Loading locations...

相似试验